SILO · NASDAQ
Silo Pharma (SILO) Stock Price & Fundamentals
Silo Pharma (SILO) closed at $674.20 on Oct 9, 2026, up 0.77% from the previous close of $669.08.
Share price, past year
1Y +21.18%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $674.20 |
| Sep 30, 2026 | $666.44 |
| Aug 31, 2026 | $660.30 |
| Jul 31, 2026 | $641.38 |
| Jun 30, 2026 | $657.45 |
| May 29, 2026 | $634.40 |
| Apr 30, 2026 | $609.59 |
| Mar 31, 2026 | $628.93 |
| Feb 27, 2026 | $591.58 |
| Jan 30, 2026 | $597.24 |
| Dec 31, 2025 | $580.93 |
| Nov 28, 2025 | $561.52 |
| Oct 31, 2025 | $550.01 |
Key statistics
- Market cap
- $760.91M
- P/E (TTM)
- 389.7
- EPS (TTM)
- $1.73
- Revenue (TTM)
- $72.10K
- Net income (TTM)
- −$4.47M
- Shares outstanding
- 1.1M
- Dividend yield
- —
- 52-week range
- $540.11 – $677.09
Silo Pharma's market cap is $760.91M, based on a share price of $674.20 and 1.1M shares outstanding as of Jun 30, 2026.
Financials
Silo Pharma reported revenue of $72.10K for fiscal 2025, unchanged 0.00% from fiscal 2024.
Silo Pharma reported a net loss of $4.23M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $72.10K | 0.0% | −$4.23M | −5,863.5% | −$0.50 | — |
| FY2024ended Dec 31, 2024 | $72.10K | 0.0% | −$4.39M | −6,092.6% | −$1.19 | — |
| FY2023ended Dec 31, 2023 | $72.10K | 0.0% | −$3.70M | −5,132.6% | −$1.20 | — |
| FY2022ended Dec 31, 2022 | $72.10K | +76.2% | −$3.91M | −5,420.9% | — | — |
| FY2020ended Dec 31, 2020 | $40.92K | +0.9% | −$3.04M | −7,422.5% | −$0.05 | — |
| FY2019ended Dec 31, 2019 | $40.57K | — | −$1.01M | −2,497.7% | −$0.04 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $18.03K | −$1.65M | −$0.12 |
| Q4 FY2025ended Dec 31, 2025 | $18.03K | −$881.53K | $2.73 |
| Q3 FY2025ended Sep 30, 2025 | $18.03K | −$1.11M | −$0.12 |
| Q2 FY2025ended Jun 30, 2025 | $18.03K | −$1.20M | −$2.88 |
| Q1 FY2025ended Mar 31, 2025 | $18.03K | −$1.03M | −$0.23 |
| Q4 FY2024ended Dec 31, 2024 | $18.03K | −$1.73M | −$0.38 |
| Q3 FY2024ended Sep 30, 2024 | $18.03K | −$928.81K | −$0.22 |
| Q2 FY2024ended Jun 30, 2024 | $18.03K | — | — |
Company profile
- Name
- Silo Pharma, Inc.
- Ticker
- SILO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 677 N. Washington Blvd, Sarasota, FL 34236
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001514183
Recent SEC filings
- Oct 2, 2026
- Aug 19, 2026
- Aug 17, 2026
- Aug 13, 2026
- Jul 13, 2026
- Jun 18, 2026
- Jun 3, 2026
- Jun 1, 2026
Frequently asked questions
What is Silo Pharma's stock price?
Silo Pharma (SILO) closed at $674.20 on Oct 9, 2026, up 0.77% from the previous close of $669.08.
What is Silo Pharma's market cap?
Silo Pharma's market cap is $760.91M, based on a share price of $674.20 and 1.1M shares outstanding as of Jun 30, 2026.
How much revenue does Silo Pharma make?
Silo Pharma reported revenue of $72.10K for fiscal 2025, unchanged 0.00% from fiscal 2024.
What is SILO's P/E ratio?
Silo Pharma's price-to-earnings ratio is 389.7, based on trailing twelve-month diluted EPS of $1.73.
Does Silo Pharma pay a dividend?
Silo Pharma's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Silo Pharma, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures